Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | AMGN | VRTX | REGN | GSK |
| Company | Halozyme Therapeutic | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 45.03 | 314.11 | 446.00 | 987.99 | 44.49 |
| High | 45.57 | 316.67 | 446.39 | 995.92 | 44.72 |
| Low | 44.71 | 311.90 | 437.46 | 982.97 | 44.46 |
| Last | 45.54 | 314.85 | 442.00 | 993.95 | 44.46 |
| Change | +0.57 | +0.31 | -3.87 | +6.68 | -0.13 |
| % Change | +1.27% | +0.10% | -0.87% | +0.68% | -0.29% |
| Volume | 915,100 | 1,705,900 | 1,106,700 | 331,600 | 3,475,000 |
| 20-Day Average Volume | 1,005,945 | 2,833,040 | 1,091,620 | 453,660 | 3,618,995 |
| Previous Close | 44.97 | 314.54 | 445.87 | 987.27 | 44.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 41.85 | 297.77 | 416.57 | 947.96 | 43.61 |
| 20-Day Raw Stochastic | 92.44% | 86.37% | 89.58% | 98.37% | 72.31% |
| 20-Day Relative Strength | 68.35% | 64.78% | 68.48% | 63.65% | 61.22% |
| Weighted Alpha | +39.58 | +42.60 | +34.49 | +36.74 | +32.48 |
| Today's Opinion | 88% Buy | 72% Buy | 72% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 88% Buy | 72% Buy | 72% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 24% Buy | 40% Sell | 8% Buy | 24% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.93% since 05/14/24 | +1.10% since 05/14/24 | +3.13% since 05/14/24 | +0.95% since 05/14/24 | -2.63% since 05/14/24 |
| Low | 44.01 on 05/15/24 | 310.37 on 05/17/24 | 428.62 on 05/15/24 | 966.00 on 05/17/24 | 44.40 on 05/20/24 |
| High | 46.16 on 05/16/24 | 321.44 on 05/15/24 | 447.85 on 05/20/24 | 995.92 on 05/21/24 | 45.92 on 05/15/24 |
| 1-Month | |||||
| %Chg | +17.86% since 04/19/24 | +17.08% since 04/19/24 | +12.10% since 04/19/24 | +10.83% since 04/19/24 | +11.85% since 04/19/24 |
| Low | 37.97 on 04/30/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 39.96 on 04/22/24 |
| High | 46.16 on 05/16/24 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 995.92 on 05/21/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | +18.72% since 02/21/24 | +11.07% since 02/21/24 | +5.33% since 02/21/24 | +4.31% since 02/21/24 | +6.01% since 02/21/24 |
| Low | 37.73 on 04/19/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 46.16 on 05/16/24 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +17.13% since 11/21/23 | +19.80% since 11/21/23 | +24.58% since 11/21/23 | +24.43% since 11/21/23 | +25.66% since 11/21/23 |
| Low | 33.15 on 02/05/24 | 260.68 on 04/19/24 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.13 on 11/22/23 |
| High | 46.16 on 05/16/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,723,512 | 168,730,256 | 115,058,088 | 108,783,320 | 92,410,096 |
| Shares Outstanding, K | 127,274 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 829,250,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | 281,590,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 195,880,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | 76,820,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.26 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.79 on 05/07/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 15.80 | 16.77 | 29.56 | 26.47 | 11.13 |